Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Citations Over TimeTop 10% of 2012 papers
Abstract
The direct nucleic acid repair dioxygenase FTO is an enzyme that demethylates N(6)-methyladenosine (m(6)A) residues in mRNA in vitro and inside cells. FTO is the first RNA demethylase discovered that also serves a major regulatory function in mammals. Together with structure-based virtual screening and biochemical analyses, we report the first identification of several small-molecule inhibitors of human FTO demethylase. The most potent compound, the natural product rhein, which is neither a structural mimic of 2-oxoglutarate nor a chelator of metal ion, competitively binds to the FTO active site in vitro. Rhein also exhibits good inhibitory activity on m(6)A demethylation inside cells. These studies shed light on the development of powerful probes and new therapies for use in RNA biology and drug discovery.
Related Papers
- → A fluorescent methylation-switchable probe for highly sensitive analysis of FTON6-methyladenosine demethylase activity in cells(2018)41 cited
- → The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B(2014)79 cited
- → Studies of the induction of microsomal S-, N- and O-demethylases(1964)20 cited
- → Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase(2020)9 cited
- → Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation(2023)